Skip to content

A Post Market Clinical follow ?up study of Humerus and Ulna System (Proximal Humerus Plate) intended for fracture fixation.

A Non ?Randomized, Prospective, Post Market Clinical follow ?up study to evaluate the Safety and Performance of Humerus and Ulna System intended for fracture fixation. - PHEELOS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044616
Enrollment
30
Registered
2022-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V00-Y99- External causes of morbidity

Interventions

Intervention1: 3.5 mm wise lock proximal humerus plate: Intended for fracture fixation for 24 months Control Intervention1: NA: NA

Sponsors

Auxein Medical Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participant has confirmed diagnosis as per the indications. 2. Subject is willing and able to give informed consent for participation in the study. 3. Male or Female, aged 18 years or above, skeletally mature patient. 4.Subject is willing and able to complete required study visits or assessments.

Exclusion criteria

Exclusion criteria: 1. Infection, local to the operative site. 2. Signs of local inflammation. 3. Pregnancy. 4. Severely comminuted fractures in which bone fragments are too small or numerous to adequately fix or maintain a reduced position 5. Patient susceptibility to allergic reaction to the components of the alloy, the implant is manufactured from. 6. Mental illness or schizophrenia, which may cause patients to ignore the limitations and precautions of the implanted material, leading to implants fracture and complication. 7. Alcohol or drug addict 8. Severe osteopenia and/or osteoporosis, or in the presence of marked or rapid bone absorption, metabolic bone disease, cancer, or any other tumor-like condition of the bone which may compromise fixation. Osteoporosis is a relative contraindication since this condition may limit the degree of obtainable correction, the amount of mechanical fixation. 9. Symptomatic Arthritis 10. Any patient having inadequate tissue coverage over the operative site or where there is inadequate bone stock, bone quality, or anatomical definition. 11. Any time implant utilization would interfere with anatomical structures or expected physiological performance. 12. Any patient unwilling to cooperate with the post-operative instructions.

Design outcomes

Primary

MeasureTime frame
To evaluate the prospective performance results of surgical treatment of patients treated with PHEELOS- 3.5 mm wise lock proximal humerus plate by: ? Pain, range of motion and power evaluation through average constant score.Timepoint: Time Frame- 1, 3, 6, 12 months postoperatively

Secondary

MeasureTime frame
To analyse the safety associated with wise lock proximal humerus along with the following. ? Quality of fusion through radiological evaluation. ? Adverse Event, complications.Timepoint: Time Frame- 1, 3, 6, 12 months postoperatively

Countries

India

Contacts

Public ContactMr Gaurav Luthra

Auxein Medical Pvt. Ltd.

m.kumar@auxein.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026